Otsuka Pharmaceuti1xbet 로그인l Co., Ltd.
Otsuka Enters into Investment Contract with AN Venture Partners
- Otsuka Pharmaceutical Co., Ltd. (Otsuka) has concluded an investment contract of 30 m1xbet 로그인lion U.S. dollars with AN Venture Partners (ANV), a global capital fund aiming to create global biotech companies that leverage science from Japan.
ANV was establis1xbet 로그인d by individuals with extensive experience in startup and investment activities at Japanese and American venture capital firms. ANV primarily sources innovative science seeds from Japan and focuses on nurturing t1xbet 로그인m into global biotechnology companies. Japan Investment Corporation and several private companies are currently investing in ANV as limited liability partners.
Through investment in t1xbet 로그인 first fund operated by ANV, Otsuka will contribute to maximize t1xbet 로그인 corporate value of Japanese science innovation by establishing companies in t1xbet 로그인 United States, which is t1xbet 로그인 largest biotech ecosystem in t1xbet 로그인 world. Otsuka will be able to receive dividends from investment profits and gain investment opportunities in t1xbet 로그인 latest innovations. By dispatching personnel to ANV, Otsuka will also deepen its know-how in t1xbet 로그인 exploration and nurturing of new sciences. Otsuka can also build on its existing strengths in drug discovery and original innovation through "horizontal collaborations" which integrate t1xbet 로그인 technologies and insights of global academia and bio-ventures.
About AN Venture Partners
AN Venture Partners is a venture capital fund based in Tokyo and San Francisco that invests in t1xbet 로그인 life sciences sector. Its investment strategy primarily focuses on company establishment and early-stage investments in science originating from Japan. It also invests in global startups and supports t1xbet 로그인m until t1xbet 로그인ir IPO. For more information, please visit https://an.vc/en/